Validating two potential hormone replacement therapy products with KOLs

Challenge: A clinical-stage company developing novel transdermal patch technology asked us to validate two potential hormone replacement therapy products with KOLs. The main focus was to evaluate the...
Learn More

Oligo technology applications mapping

Challenge: A startup with a novel technology for enzymatic synthesis of dsDNA approached Alacrita to assess potential opportunities for the technology in the biopharma space. Hitherto the company had...
Learn More

LNP technology and competitive landscape

Challenge: A privately held biotech company using AI/machine learning/Big Data to develop novel LNPs and LNP formulations for particular payloads instead of using a traditional “trial and error”...
Learn More

Landscape Analysis of the Radiopharma Market

Challenge: A VC investor considering funding a radiopharmaceutical company requested an analysis of the therapeutic radiopharmaceutical landscape, to help them evaluate the investment. The purpose of...
Learn More

Assessment of TLR immunomodulators in oncology and HIV

Challenge:  A European publicly-listed biotech was facing a Phase III milestone for its lead immunomodulator and had a next generation technology in IND-enabling studies. The company was operating in...
Learn More

Commercial development plan for a mesenchymal stem cell therapy in acute GvHD

Challenge: Our client was a leading UK Research Institute requiring assistance in assigning internal commercialization funding to the most promising research groups within the university. Alacrita...
Learn More

Opportunity map for 3D Printing Technology for medical products

Challenge: A university commercialization institute asked Alacrita to review its technology for 3D printed, customised silicone medical products. The main task was to determine the prospective value...
Learn More

T cell therapy commercialization plan

Challenge: The commercialization arm of a leading university wished to identify its most promising therapeutic programs within its purview in order to allocate internal translational funding to...
Learn More

Opportunity analysis of phage technology

Challenge:  An Israeli university technology transfer organization asked Alacrita to explore the different potential commercialization pathways for a novel platform technology. The overall effect of...
Learn More

R&D pipeline planning for gene therapy company

Challenge: A biotechnology company developing proprietary synthetic biology technology in gene therapy expression for several clients was looking to evolve its business model. The company engaged...
Learn More

Commercial development plan for a CAR-T therapy in head & neck cancer

Challenge Our client was a leading UK Research Institute requiring assistance in assigning internal commercialization funding to the most promising research groups within the University. Alacrita was...
Learn More

Commercial development plan for CAR-T therapy

Challenge Our client was a leading UK Research Institute requiring assistance in assigning internal commercialization funding to the most promising research groups within the University. Alacrita was...
Learn More
1 2